(19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium Salt

• 产品号: H825292
• 分子式: C53H82NNaO14
• 分子量: 980.20625

产品别名

• 标题: (19E/Z)-seco-[4-O-[2-Hydroxy(ethyl)-d4]] Rapamycin Sodium Salt
• IUPAC标准名: sodium (2S)-1-{2-[(2R,3R,6S)-2-hydroxy-6-[(2R,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-21-{[(1S,3S,4R)-4-[2-hydroxy(^2H₄)ethoxy]-3-methoxycyclohexyl]methyl}-2,13-dimethoxy-3,9,11,15,17-pentamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl]-3-methyloxan-2-yl]-2-oxoacetyl}piperidine-2-carboxylate
• IUPAC传统名: sodium (2S)-1-{2-[(2R,3R,6S)-2-hydroxy-6-[(2R,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-21-{[(1S,3S,4R)-4-[2-hydroxy(^2H₄)ethoxy]-3-methoxycyclohexyl]methyl}-2,13-dimethoxy-3,9,11,15,17-pentamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl]-3-methyloxan-2-yl]-2-oxoacetyl}piperidine-2-carboxylate
• 别名: ########

产品详细信息

详细说明 (English)

A labelled metabolite of the immunosuppressant macrolide SDZ RAD (also known as Everolimus E945400) which is an analog of the parent drug Rapamycin (R124000).

参考文献

• Vidal, C. et al.: J. Am. Soc. Mass Spec., 9, 1267 (1998); Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001);